Literature DB >> 17048076

Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control.

B Shannan1, M Seifert, D A Boothman, W Tilgen, J Reichrath.   

Abstract

The glycoprotein clusterin (CLU), has two known isoforms generated in human cells. A nuclear form of CLU protein (nCLU) is pro-apoptotic, while a secretory form (sCLU) is pro-survival. Both forms are implicated in various cell functions, including DNA repair, cell cycle regulation, and apoptotic cell death. CLU expression has been associated with tumorigenesis and the progression of various malignancies. In response to DNA damage, cell survival can be enhanced by activation of DNA repair mechanisms, while simultaneously stimulating energy-expensive cell cycle checkpoints that delay the cell cycle progression to allow more time for DNA repair. This review summarizes our current understanding of the role of clusterin in DNA repair, apoptosis, and cell cycle control and the relevance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048076     DOI: 10.1007/s10735-006-9052-7

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  35 in total

1.  Synthesis and functional analyses of nuclear clusterin, a cell death protein.

Authors:  Konstantin S Leskov; Dmitry Y Klokov; Jing Li; Timothy J Kinsella; David A Boothman
Journal:  J Biol Chem       Date:  2003-01-24       Impact factor: 5.157

Review 2.  Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.

Authors:  B Shannan; M Seifert; K Leskov; J Willis; D Boothman; W Tilgen; J Reichrath
Journal:  Cell Death Differ       Date:  2006-01       Impact factor: 15.828

3.  Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.

Authors:  Tobias Zellweger; Kim Chi; Hideaki Miyake; Hans Adomat; Satoshi Kiyama; Kirsten Skov; Martin E Gleave
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

4.  Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2'-O-(2-methoxy)ethyl chemistry.

Authors:  T Zellweger; H Miyake; S Cooper; K Chi; B S Conklin; B P Monia; M E Gleave
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

Review 5.  Antisense targets to enhance hormone and cytotoxic therapies in advanced prostate cancer.

Authors:  Martin Gleave; Colleen Nelson; Kim Chi
Journal:  Curr Drug Targets       Date:  2003-04       Impact factor: 3.465

Review 6.  Cyclin-dependent kinases as targets for cancer therapy.

Authors:  Manish A Shah; Gary K Schwartz
Journal:  Cancer Chemother Biol Response Modif       Date:  2003

Review 7.  Clusterin/apolipoprotein J in human aging and cancer.

Authors:  Ioannis P Trougakos; Efstathios S Gonos
Journal:  Int J Biochem Cell Biol       Date:  2002-11       Impact factor: 5.085

8.  Androgen-repressed messages in the rat ventral prostate.

Authors:  M L Montpetit; K R Lawless; M Tenniswood
Journal:  Prostate       Date:  1986       Impact factor: 4.104

9.  Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo.

Authors:  Laura V July; Eliana Beraldi; Alan So; Ladan Fazli; Kenneth Evans; John C English; Martin E Gleave
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

10.  Efficient suppression of secretory clusterin levels by polymer-siRNA nanocomplexes enhances ionizing radiation lethality in human MCF-7 breast cancer cells in vitro.

Authors:  Damon Sutton; Saejeong Kim; Xintao Shuai; Konstantin Leskov; Joao T Marques; Bryan R G Williams; David A Boothman; Jinming Gao
Journal:  Int J Nanomedicine       Date:  2006
View more
  28 in total

Review 1.  The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Authors:  Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

Review 2.  Biomarkers of Drug-Induced Kidney Toxicity.

Authors:  Benjamin R Griffin; Sarah Faubel; Charles L Edelstein
Journal:  Ther Drug Monit       Date:  2019-04       Impact factor: 3.681

3.  Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel.

Authors:  Mohamed Kamel Hassan; Hidemichi Watari; Lane Christenson; Saverio Bettuzzi; Noriaki Sakuragi
Journal:  Tumour Biol       Date:  2011-07-15

Review 4.  Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.

Authors:  Tobias Christian Fuchs; Philip Hewitt
Journal:  AAPS J       Date:  2011-10-04       Impact factor: 4.009

5.  Clusterin is a gene-specific target of microRNA-21 in head and neck squamous cell carcinoma.

Authors:  Wojciech Mydlarz; Mamoru Uemura; Sun Ahn; Patrick Hennessey; Steven Chang; Semra Demokan; Wenyue Sun; Chunbo Shao; Justin Bishop; Julie Krosting; Elizabeth Mambo; William Westra; Patrick Ha; David Sidransky; Joseph Califano
Journal:  Clin Cancer Res       Date:  2013-12-10       Impact factor: 12.531

6.  Gene expression profiling in sinonasal adenocarcinoma.

Authors:  Dominique Tripodi; Sylvia Quéméner; Karine Renaudin; Christophe Ferron; Olivier Malard; Isabelle Guisle-Marsollier; Véronique Sébille-Rivain; Christian Verger; Christian Géraut; Catherine Gratas-Rabbia-Ré
Journal:  BMC Med Genomics       Date:  2009-11-10       Impact factor: 3.063

7.  Multidimensional liquid chromatography platform for profiling alterations of clusterin N-glycosylation in the plasma of patients with renal cell carcinoma.

Authors:  Fateme Tousi; Jonathan Bones; Othon Iliopoulos; William S Hancock; Marina Hincapie
Journal:  J Chromatogr A       Date:  2012-07-28       Impact factor: 4.759

8.  Vanadium-induced apoptosis of HaCaT cells is mediated by c-fos and involves nuclear accumulation of clusterin.

Authors:  Soultana Markopoulou; Evangelos Kontargiris; Christina Batsi; Theodore Tzavaras; Ioannis Trougakos; David A Boothman; Efstathios S Gonos; Evangelos Kolettas
Journal:  FEBS J       Date:  2009-06-15       Impact factor: 5.542

9.  Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma.

Authors:  Mee Lee Looi; Saiful Anuar Karsani; Mariati Abdul Rahman; Ahmad Zailani Hatta Mohd Dali; Siti Aishah Md Ali; Wan Zurinah Wan Ngah; Yasmin Anum Mohd Yusof
Journal:  J Biosci       Date:  2009-12       Impact factor: 1.826

10.  Analysis of newly established EST databases reveals similarities between heart regeneration in newt and fish.

Authors:  Thilo Borchardt; Mario Looso; Marc Bruckskotten; Patrick Weis; Julia Kruse; Thomas Braun
Journal:  BMC Genomics       Date:  2010-01-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.